Stomach ailment [gastric disorder].Case (b)(4) is a serious, spontaneous case received from a non health professional via a regulatory authority in the united states.This report concerns a patient of unknown age and gender who experienced a stomach ailment during treatment with euflexxa (sodium hyaluronate) solution for injection, unknown concentration, unknown dose and route of administration, for an unknown indication from an unknown start date to an unknown stop date.It as reported that on (b)(6) 2018 the patient was hospitalized for an unknown stomach ailment and does not know how long the hospitalization will be.The issue was not related to the medicine.Arxwo has not yet filled this medication for the patient.The patient was hospitalized on an unknown date due to stomach ailment.Action taken with euflexxa was unknown.At the time of this report, the outcome of stomach ailment was unknown.Concomitant medication was not reported.All events in the case were reported as serious.At the time of reporting the case outcome was unknown.Overall listedness (core label) is unlisted.Reporter causality: not related.Company causality: not related.Other case numbers: case number, others = mw5077974.This ae occurred in the us and concerns the medical device euflexxa.Please report to your local health authority if required by local law.This ae is not reportable in eu because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer.No corrective action was done by the manufacturer or requested by regulators.
|